by | Jan 15, 2025 | Cloonan, Paige, Kamath, Ashwin, Leuthardt, Eric, MacEwan, Matthew, Moore, Amy, Moran, Daniel, Qin, Yidan (Ida), Ray, Wilson, Zhang, Christopher
— Published date: 1/15/2025
Value Proposition: Implantable electrode device that can treat a plurality of medical diseases by stimulating or inhibiting select regions of sympathetic nervous system.
Technology Description
Researchers at Washington University in St. Louis have developed “SIMP…
by | Jan 15, 2025 | Cloonan, Paige, Kamath, Ashwin, Leuthardt, Eric, MacEwan, Matthew, Moore, Amy, Moran, Daniel, Qin, Yidan (Ida), Ray, Wilson, Zhang, Christopher
— Published date: 1/15/2025
Value Proposition: Implantable electrode device that can treat a plurality of medical diseases by stimulating or inhibiting select regions of sympathetic nervous system.
Technology Description
Researchers at Washington University in St. Louis have developed “SIMP…
by | Oct 13, 2023 | Dodson, Karen, Ellebedy, Ali, Feldman, Mario, Hultgren, Scott, Pinkner, Jerome, Tamadonfar, Kevin, Timm, Morgan
— Technology Description
Researchers in Scott Hultgren’s laboratory at Washington University have created two prospective vaccine treatments designed to prevent the colonization of prominent uropathogens. These vaccines have potential for treating urinary tract infections (UTIs) with specific m…
by | Sep 24, 2020 | Song, Sheng-Kwei "Victor", Ye, Zezhong
— Researchers in Prof. Sheng-Kwei (Victor) Song’s laboratory have developed diffusion histology imaging (“DHI”), a tool to provide a non-invasive diagnosis for accurately grading tumors and guiding treatment decisions. This “virtual histopathology” technology classifies mic…
by | Jun 9, 2020 | Chaudhuri, Aadel, Maher, Christopher, Pachynski, Russell
— Technology Description
A team of researchers at Washington University has developed “EnhanceAR-Seq”, a circulating tumor DNA (ctDNA) assay that predicts which patients are at high risk for developing resistance to androgen receptor (AR)-directed treatment for metastatic prostate cancer…